Epinephrine promotes development potential of vitrified mouse oocytes

Area of Science:

• Reproductive Biology
• Cryobiology
• Cellular Physiology

Background:

• Cryopreservation of oocytes is crucial for fertility preservation but often results in reduced developmental competence.
• Understanding the mechanisms behind impaired oocyte development post-vitrification is essential for improving success rates.

Purpose of the Study:

• To investigate the effect of epinephrine on the in vitro developmental competence of vitrified mouse oocytes.
• To explore the underlying mechanisms, including oxidative stress and energy metabolism.

Main Methods:

• Mature mouse oocytes were vitrified using the Open Pulled Straw (OPS) method.
• Vitrified oocytes were treated with varying concentrations of epinephrine (10⁻² to 10⁻⁸ mol L⁻¹).
• Oocyte survival, in vitro fertilization (IVF) rates, blastocyst development, intracellular reactive oxygen species (ROS), glutathione (GSH), and adenosine triphosphate (ATP) levels were assessed.

Main Results:

• Epinephrine at 10⁻⁴ mol L⁻¹ significantly increased cleavage (66.4% vs. 45.2%) and blastocyst formation rates (47.2% vs. 34.7%) compared to controls.
• This concentration also led to more blastocyst cells (54.5 vs. 36.8) and a lower apoptotic cell ratio (5.9% vs. 21.5%).
• Epinephrine treatment reduced intracellular ROS levels and enhanced cytoplasmic ATP concentration, without affecting GSH levels.

Conclusions:

• Epinephrine significantly promotes the cryosurvival and subsequent developmental ability of vitrified mouse oocytes.
• The beneficial effects of epinephrine may be attributed to the reduction of intracellular ROS and the enhancement of cellular ATP content.
• Epinephrine represents a promising agent for improving oocyte cryopreservation protocols.